Sight Diagnostics, an OurCrowd portfolio company, is helping to lead the response to the Coronavirus pandemic. Sight’s OLO, a compact blood analyzer that can provide rapid, lab-grade CBC [complete blood count] results, has been installed in Sheba Tel Hashomer’s (Israel’s largest hospital that is supported… Read More
We all know the story of Elizabeth Holmes and the demise of Theranos, a company that claimed to have created a device that could provide fast and efficient blood tests. Theranos ended being a company based on hubris, imagination, and vapor. It eventually collapsed being… Read More
OurCrowd has joined in the Series C funding of Medtech firm Sight Diagnostics. The company is creating a lab-grade point-of-care blood diagnostics system “OLO.” This system is designed to provide patients with lab-grade blood testing results in minutes rather than days by combining AI with… Read More
Crowdfund Insider is the leading news website covering the emerging global industry of disruptive finance including investment crowdfunding, Blockchain, online lending, and other forms of Fintech.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it and agree to our terms of service.Ok